Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.1450 (-0.83%) ($10.1450 - $10.1450) on Fri. Jan. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 42 | Latest Price | $10.1450(-0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -3.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(34%) ARKG(32%) IBB(31%) SDY(27%) IFRA(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.84% in a week (0% probabilities). VIXM(-17%) UUP(-9%) VXX(-7%) USO(-4%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.82(-82.06%) | Resistance Level | $10.98 | 5 Day Moving Average | $10.34(-1.89%) | 10 Day Moving Average | $10.95(-7.35%) | 20 Day Moving Average | $10.98(-7.6%) | To recent high | -28% | To recent low | 1.1% | Market Cap | $1.79b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |